Recent research suggests that the prognostic value of the CFH gene may be driven primarily by the FHL-1 isoform rather than the circulating full-length protein. In the rapidly shifting landscape of 2026 oncology, identifying reliable prognostic biomarkers has become the cornerstone of improving
Transcriptomic profiling reveals that suppressing β-catenin in specific mutant cells leads to an overwhelming accumulation of ubiquitinated proteins and cellular stress. This biological response marks a turning point in the treatment of advanced endometrial cancer, which remains a leading cause of
The resignation of FDA Commissioner Marty Makary on May 12, 2026, effectively unblocked the administrative queue for scheduling critical drug and device advisory meetings. This shift signals a broader effort to revitalize a system that has long been the backbone of regulatory transparency. The
Introduction Texas is currently navigating a pivotal moment in public health as it confronts the reality that a disease which is almost entirely preventable continues to affect thousands of women across the state every year. During the Cancer Prevention and Research Institute of Texas 2026
The design flexibility of bioprinted vascular platforms allows for the customization of cell ratios and geometries to meet the specific needs of individual patients. This high level of precision is particularly vital in 2026, as the medical community continues to face the mounting challenge of
The development of a gelatin methacryloyl hydrogel scaffold provides a biocompatible framework that mimics the natural extracellular matrix for cell growth. This innovation, spearheaded by Professor Jun Liu and a dedicated research team at Sichuan University, marks a pivotal advancement in the
